Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
Renieri A, Mencarelli MA, Cetta F, Baldassarri M, Mari F, Furini S, Piu P, Ariani F, Dragani TA, Frullanti E.
Lung Cancer. 2014 Aug;85(2):168-74. doi: 10.1016/j.lungcan.2014.05.020.
Epub 2014 Jun 4.

2014

Assessment of circulating microRNAs in plasma of lung cancer patients.
Fortunato O, Boeri M, Verri C, Conte D, Mensah M, Suatoni P, Pastorino U, Sozzi G
Molecules. 2014 Mar 10;19(3):3038-54. doi: 10.3390/molecules19033038.

2014

Senescent stroma promotes prostate cancer progression: The role of miR-210.
Taddei ML, Cavallini L, Comito G, Giannoni E, Folini M, Marini A, Gandellini P, Morandi A, Pintus G, Raspollini MR, Zaffaroni N, Chiarugi P
Mol Oncol. 2014 Dec;8(8):1729-46. doi: 10.1016/j.molonc.2014.07.009.
Epub 2014 Jul 21.

2014

miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells.
Pennati M, Lopergolo A, Profumo V, De Cesare M, Sbarra S, Valdagni R, Zaffaroni N, Gandellini P,
Folini M
Biochem Pharmacol. 2014 Feb 15;87(4):579-97. doi: 10.1016/j.bcp.2013.12.009.
Epub 2013 Dec 24.

2014

miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts.
Gandellini P, Giannoni E, Casamichele A, Taddei ML, Callari M, Piovan C, Valdagni R, Pierotti MA, Zaffaroni N, Chiarugi P
Antioxid Redox Signal.
2014 Mar 1;20(7):1045-59.
doi: 10.1089/ars.2013.5292.
Epub 2013 Sep 17.

2014

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.
Triulzi T, Ratti M, Tortoreto M, Ghirelli C, Aiello P, Regondi V, Modica MD, Cominetti D, Carcangiu ML, Moliterni A, Balsari A, Casalini P, Tagliabue E
Int J Cancer.
2014 Jun 15;134(12):2789-97.
doi: 10.1002/ijc.28608.
Epub 2013 Nov 30

2014

Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study.
Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, Roz L, Conte D, Grassi M, Sverzellati N, Marchiano A, Negri E, La Vecchia C,
Pastorino U
J Clin Oncol. 2014 Mar 10;32(8):768-73. doi: 10.1200/JCO.2013.50.4357.
Epub 2014 Jan 13.

2014

NqA: an R-based algorithm for the normalization and analysis of microRNA quantitative real-time polymerase chain reaction data.
Verderio P, Bottelli S, Ciniselli CM, Pierotti MA, Gariboldi M, Pizzamiglio S
Anal Biochem.
2014 Sep 15;461:7-9.
doi: 10.1016/j.ab.2014.05.020.
Epub 2014 Jun 2.

2014

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer.
Crippa E, Lusa L, De Cecco L, Marchesi E, Calin GA, Radice P, Manoukian S, Peissel B, Daidone MG, Gariboldi M, Pierotti MA
PLoS One. 2014 Jan 27;9(1):e87039. doi: 10.1371/journal.pone.0087039.
eCollection 2014.

2014

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer.
Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Ravagnani F, Perrone F, Leo E, Pilotti S, Verderio P, Gariboldi M, Pierotti MA
Br J Cancer.
2014 Feb 18;110(4):1001-7.
doi: 10.1038/bjc.2013.819.
Epub 2014 Jan 14.

2014

Circulating free DNA in a screening program for early colorectal cancer detection.
Perrone F, Lampis A, Bertan C, Verderio P, Ciniselli CM, Pizzamiglio S, Frattini M, Nucifora M, Molinari F, Gallino G, Gariboldi M, Meroni E, Leo E, Pierotti MA, Pilotti S
Tumori.
2014 Mar-Apr;100(2):115-21.
doi: 10.1700/1491.16389.

2014

A normalization strategy for the analysis of plasma microRNA qPCR data in colorectal cancer.
Pizzamiglio S, Bottelli S, Ciniselli CM, Zanutto S, Bertan C, Gariboldi M, Pierotti MA, Verderio P
Int J Cancer.
2014 Apr 15;134(8):2016-8.
doi: 10.1002/ijc.28530.
Epub 2013 Oct 22.

2014

Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.
Sangaletti S, Tripodo C, Portararo P, Dugo M, Vitali C, Botti L, Guarnotta C, Cappetti B, Gulino A, Torselli I, Casalini P, Chiodoni C, Colombo MP
Oncoimmunology. 2014 Jun 5;3:e28989. eCollection 2014.

2014

Osteopontin shapes immune suppression in the metastatic niche.
Sangaletti S, Tripodo C, Sandri S, Torselli I, Vitali C, Ratti C, Botti L, Burocchi A, Porcasi R, Tomirotti A, Colombo MP, Chiodoni C
Cancer Res. 2014 Sep 1;74(17):4706-19. doi: 10.1158/0008-5472.CAN-13-3334. Epub 2014 Jul 17.

2014

Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma.
Sangaletti S, Tripodo C, Vitali C, Portararo P, Guarnotta C, Casalini P, Cappetti B, Miotti S, Pinciroli P, Fuligni F, Fais F, Piccaluga PP, Colombo MP
Cancer Discov. 2014 Jan;4(1):
110-29. doi: 10.1158/2159-8290.
CD-13-0276. Epub 2013 Nov 4.

2014

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma.
Franco G, Guarnotta C, Frossi B, Piccaluga PP, Boveri E, Gulino A, Fuligni F, Rigoni A, Porcasi R, Buffa S, Betto E, Florena AM, Franco V, Iannitto E, Arcaini L, Pileri SA, Pucillo C, Colombo MP, Sangaletti S, Tripodo C
Blood. 2014 Mar 20;123(12):1836-49. doi: 10.1182/
blood-2013-04-497271.
Epub 2014 Jan 22.

2014

Therapeutic Use of MicroRNAs in Lung Cancer.
Fortunato O, Boeri M, Verri C, Moro M, Sozzi G
Biomed Res Int. 2014;2014:756975. doi: 10.1155/2014/756975.
Epub 2014 Sep 16

2014

Potential biomarkers for lung cancer screening.
Sozzi G, Boeri M
Transl Lung Cancer Res.
2014 Jun;3(3):139-48.
doi: 10.3978/j.issn.2218-
6751.2014.06.04.

2014

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O, Boeri M, Moro M, Verri C, Mensah M, Conte D, Caleca L, Roz L, Pastorino U,
Sozzi G
Cell Death Dis.
2014 Dec 11;5:e1564.
doi: 10.1038/cddis.2014.507.

2014

Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.
Callari M, Musella V, Di Buduo E, Sensi M, Miodini P, Dugo M, Orlandi R, Agresti R, Paolini B, Carcangiu ML, Cappelletti V, Daidone MG. 
Mol Oncol. 2014 Oct;8(7):1278-89.
doi: 10.1016/
j.molonc.2014.04.010.
Epub 2014 May 4.

2014

A lipemia-independent NanoDrop(®)-based score to identify hemolysis in plasma and serum samples.
Appierto V, Callari M, Cavadini E, Morelli D, Daidone MG, Tiberio P.
Bioanalysis.
2014 May;6(9):1215-26.
doi: 10.4155/bio.13.344.

2014

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Progetto finanziato con

il contributo Airc 5x1000

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié